SCHEMBL26420940

SCHEMBL26420940

c1ccc(-c2cc(-c3cccc4sc5cc(-c6ccc(N(c7ccccc7)c7ccccc7)cc6)ccc5c34)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 9/20 0.37
KMT2A Q03164 9/20 0.37
MAPT P10636 7/20 0.37
ALDH1A1 P00352 6/20 0.37
HPGD P15428 6/20 0.37
NTSR1 P30989 1/20 0.37
KDM4E B2RXH2 4/20 0.36
LMNA P02545 3/20 0.36
GLA P06280 1/20 0.36
MAOB P27338 5/20 0.34
MAOA P21397 3/20 0.34
LIMK1 P53667 1/20 0.33
TDP1 Q9NUW8 2/20 0.33
ADORA2A P29274 2/20 0.33
ADORA1 P30542 2/20 0.33
MAPK1 P28482 1/20 0.33
CYP2C19 P33261 2/20 0.32
NPSR1 Q6W5P4 1/20 0.32
RXFP1 Q9HBX9 1/20 0.32
PIK3CA P42336 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26420632 0.94 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL26420647 0.93 MEN1 (0.34) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25850585 0.92 MEN1 (0.36) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL26416755 0.90 LIMK1 (0.34) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL26416754 0.90 LIMK1 (0.34) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22700716 0.90 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22700714 0.90 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22700722 0.90 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22700717 0.90 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL22700715 0.90 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE LT MATERIALS CO., LTD. (KR) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320211-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME, AND COMPOSITION FOR ORGANIC MATERIAL LAYER OF ORGANIC LIGHT-EMITTING DEVICE ORC3, CRY1, SUN2 MEN1 1044/4885KMT2A 1149/4885MAPT 340/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.